Utpal Koppikar
2018
In 2018, Utpal Koppikar earned a total compensation of $4.2M as Chief Financial Officer at Atara Biotherapeutics.
Compensation breakdown
| Bonus | $189,771 |
|---|---|
| Option Awards | $1,886,325 |
| Salary | $240,289 |
| Stock Awards | $1,903,500 |
| Other | $398 |
| Total | $4,220,282 |
Koppikar received $1.9M in stock awards, accounting for 45% of the total pay in 2018.
Koppikar also received $189.8K in bonus, $1.9M in option awards, $240.3K in salary and $398 in other compensation.
Rankings
In 2018, Utpal Koppikar's compensation ranked 2,596th out of 14,244 executives tracked by ExecPay. In other words, Koppikar earned more than 81.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,596 out of 14,244 | 82nd |
Division Manufacturing | 954 out of 5,759 | 83rd |
Major group Chemicals And Allied Products | 324 out of 2,122 | 85th |
Industry group Drugs | 263 out of 1,811 | 86th |
Industry Biological Products, Except Diagnostic Substances | 53 out of 339 | 84th |
Source: SEC filing on April 22, 2020.
Koppikar's colleagues
We found four more compensation records of executives who worked with Utpal Koppikar at Atara Biotherapeutics in 2018.